Ertapenem Sodium
Who holds supplier records for Ertapenem Sodium? 7 organisations hold a current record for Ertapenem Sodium: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (4), China (2) and Italy (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Ertapenem Sodium: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/ertapenem-sodium
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ertapenem Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Shandong Anhong Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 37232, 30709 · latest filing Aug 2022
- ACS DOBFAR SPAItaly Company GMP cert on recordActive DMF 29102 · latest filing Apr 2015
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 30311 · latest filing Mar 2016
- Gland Chemicals Private LimitedIndiaActive DMF 40191 · latest filing Sept 2024
- GLAND PHARMA LTDIndia Company GMP cert on recordActive DMF 32424 · latest filing Jan 2018
- JILIN ASYMCHEM PHARMACEUTICALS CO LTDChinaActive DMF 37463 · latest filing Mar 2023
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia Company GMP cert on recordActive DMF 28391 · latest filing Jun 2014
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Ertapenem Sodium are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- India · Inactive DMF 30123 · filed Jan 2016
- ASYMCHEM LABORATORIES FUXIN CO LTDInactive DMF 29473 · filed Jun 2015
- PFIZER HEALTHCARE INDIA PVT LTDInactive DMF 27348 · filed Sept 2013
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Ertapenem Sodium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1232).
Chemical identity
- IUPAC name
- sodium 3-[[(2S,4S)-4-[[(4R,5S,6S)-2-carboxy-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]sulfanyl]pyrrolidine-2-carbonyl]amino]benzoate
- Canonical SMILES
- C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)[O-])C(=O)O)[C@@H](C)O.[Na+]
- InChIKey
- ZXNAQFZBWUNWJM-HRXMHBOMSA-M
- Synonyms
- Ertapenem sodium, Ertapenem sodium salt, Ertapenem sun, Invanz, L-749345, MK-0826, MK-826
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Penem Antibacterial
- Chemical structure
- Carbapenems
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ertapenem Sodium?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Ertapenem Sodium: Shandong Anhong Pharmaceutical Co., Ltd. (China), ACS DOBFAR SPA (Italy), APITORIA PHARMA PRIVATE LTD (India), Gland Chemicals Private Limited (India), GLAND PHARMA LTD (India), JILIN ASYMCHEM PHARMACEUTICALS CO LTD (China) and SOLARA ACTIVE PHARMA SCIENCES LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ertapenem Sodium Drug Master Files are active?
Shandong Anhong Pharmaceutical Co., Ltd. (DMF 37232, 30709), ACS DOBFAR SPA (DMF 29102), APITORIA PHARMA PRIVATE LTD (DMF 30311), Gland Chemicals Private Limited (DMF 40191), GLAND PHARMA LTD (DMF 32424), JILIN ASYMCHEM PHARMACEUTICALS CO LTD (DMF 37463) and SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 28391). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Ertapenem Sodium records mean?
3 organisations have only inactive Type II DMFs for Ertapenem Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Ertapenem Sodium supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ertapenem Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.